Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Deep Blue Med Spa Announces New Profound Procedure to Treat Wrinkles and Rejuvenate Jawline | ||
By: Nasdaq / GlobeNewswire - 13 Dec 2018 | Back to overview list |
|
LONG ISLAND, NY, Dec. 13, 2018 (GLOBE NEWSWIRE) -- Deep Blue Med Spa, overseen by the plastic surgeons at Long Island Plastic Surgical Group, is pleased to announce the addition of Profound, a unique microneedling radiofrequency therapy, to its range of rejuvenating treatments and cosmetic procedures at locations in Garden City, East Hills, Babylon, and Manhattan. Deep Blue Med Spa is the first multi-location practice in the New York City metropolitan area to offer Profound. The experienced anti-aging specialists at Deep Blue Med Spa understand that visible signs of aging can have a negative effect on self-esteem and we strive to offer enhancing treatments that promote renewal and bolster confidence. The condition of our skin is fundamental to a youthful appearance, and as we age collagen, elastin and hyaluronic acid production begin to wane. Fortunately, leading global aesthetic manufacturer Syneron Candela has developed Profound, a radiofrequency microneedling system that has been clinically proven to stimulate natural creation of all three of these epidermal building blocks. A single Profound treatment can have significant smoothing and lifting effects and is ideal for treating a sagging chin, creating a defined jawline or refreshing a tired mid-face. "We’re are thrilled to add Profound as an effective option for New York and Long Island patients who are seeking to lift, contour, and volumize with a single non-surgical treatment,” said Dr. Laurence T. Glickman, Medical Director of Deep Blue Med Spa. "Profound is a powerful tool that combines two effective technologies for even greater performance and noticeable anti-aging results for patients who are not candidates or are not ready for a surgical facelift.” Profound, developed by medical device leader Syneron Candela, is an FDA-approved device indicated for use in dermatologic and general surgical procedures for electrocoagulation and hemostasis. Specifically, the 25º Dermal handpiece and cartridge are used for the percutaneous treatment of facial wrinkles, and the 75º SubQ handpiece and cartridge are used to improve the appearance of cellulite in patients with Fitzpatrick skin types I-III as supported by long-term clinical data (6 months). Remarkably, only one 45 to 90-minute Profound treatment is needed. Most patients resume normal activities within 24 to 48 hours. Clinical studies reveal a 100 percent response rate for wrinkles. "The FDA clearance of Profound for the treatment of cellulite is a major addition to the capabilities of Profound and body contouring options. Cellulite is one of the most disturbing aesthetic problems bothering women and one of the most difficult to treat. Cellulite is also one of the most prevalent aesthetic conditions bothering women at all ages, it is estimated that between 85-98% of adult women suffer from cellulite. This FDA clearance provides a new treatment opportunity for patients with minimal discomfort and downtime" said Ross Portaro, Vice President, Syneron Candela, Profound Global Business Unit. "We are thrilled that Deep Blue Med Spa is able to add to their services a long-term solution to improve the appearance of cellulite that is complementary to their existing services.” To learn more about Profound or to request a consultation, call (516) 665-1922 or visit deepbluemedspa.com. About Deep Blue Med Spa Garden City East Hills Babylon Manhattan |
||
|
||
Copyright 2018 Nasdaq / GlobeNewswire | Back to overview list |